CARDIOME UK LIMITED

06304464
Dissolved London

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical products
C

CARDIOME UK LIMITED

06304464

Manufacture of basic pharmaceutical products

Founded 6 Jul 2007 Dissolved London, United Kingdom 0 employees website.com
Manufacture of basic pharmaceutical products
Accounts Submitted 7 Sept 2023
Confirmation Submitted 14 Aug 2023 Next due 14 Aug 2024 23 months overdue
Net assets £0
Total assets £0
Total Liabilities £0
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Dashwood House 69 Old Broad Street London EC2M 1QS United Kingdom

Full company profile for CARDIOME UK LIMITED (06304464), a dissolved company based in London, United Kingdom. Incorporated 6 Jul 2007. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2021
Type dormant
Next accounts
Due by

Balance Sheet & P&L (2013–2021)

Cash in Bank

N/A

Net Assets

N/A

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2021
31 Dec Year End
2020
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Correvio Pharma Corp.
100.0%
100
Cardiome Pharma Corp
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 1 Jun 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Correvio Pharma Corp

Ceased 27 May 2020

Ceased

The Blackstone Group Inc.

Ceased 1 Jun 2021

Ceased

Group Structure

Group Structure

CARDIOME UK LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Oct 2024GazetteGazette Dissolved Voluntary
23 Jul 2024GazetteGazette Notice Voluntary
11 Jul 2024DissolutionDissolution Application Strike Off Company
7 Sept 2023AccountsAnnual accounts made up to 31 Dec 2022
16 Aug 2023Persons With Significant ControlChange to Mercury Pharma Group Limited as a person with significant control on 1 Aug 2023
8 Oct 2024 Gazette

Gazette Dissolved Voluntary

23 Jul 2024 Gazette

Gazette Notice Voluntary

11 Jul 2024 Dissolution

Dissolution Application Strike Off Company

7 Sept 2023 Accounts

Annual accounts made up to 31 Dec 2022

16 Aug 2023 Persons With Significant Control

Change to Mercury Pharma Group Limited as a person with significant control on 1 Aug 2023

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 8 Oct 2024

Gazette Notice Voluntary

1 years ago on 23 Jul 2024

Dissolution Application Strike Off Company

1 years ago on 11 Jul 2024

Annual accounts made up to 31 Dec 2022

2 years ago on 7 Sept 2023

Change to Mercury Pharma Group Limited as a person with significant control on 1 Aug 2023

2 years ago on 16 Aug 2023